Fungal Keratitis
3
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Angeles TherapeuticsCA - Los Angeles
1 program1
povidone-iodine 1.25% ophthalmic solutionPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Angeles Therapeuticspovidone-iodine 1.25% ophthalmic solution
IVIEW TherapeuticsIVIEW-1201
Clinical Trials (2)
Total enrollment: 138 patients across 2 trials
A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine
Start: Mar 2008Est. completion: Dec 201078 patients
Phase 3Terminated
Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis
Start: Aug 2026Est. completion: Dec 202760 patients
Phase 2Not Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.